Mettler-Toledo International, Inc. MTD

1,511.64 (7.51) (0.49%) as of 25 Sep
Market cap
$30.4B
P/E
33.9×
Indexes indicate stock being part of an index

Mettler-Toledo International, Inc. (MTD) EV/Sales

As of 25 September 2026, Mettler-Toledo International, Inc. (MTD) trades at a EV/Sales of 7.9×. Over the past ten years it has ranged from 3.4× (September 2015) to 11.3× (December 2021); the current reading is higher than 71% of that period. That is above the Diagnostics & Research industry median of 5.7× and above the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 7.7× 6.15%
FY2024 7.2× (4.28%)
FY2023 7.5× (15.15%)
FY2022 8.9× (19.18%)
FY2021 11.0× 19.08%
FY2020 9.2× 34.90%
FY2019 6.8× 32.77%
FY2018 5.2× (17.11%)
FY2017 6.2× 30.57%
FY2016 4.8× 15.39%

Quarterly

Period EV/Sales Change
Jun 2026 6.7× (1.02%)
Mar 2026 6.8× (11.35%)
Dec 2025 7.7× 10.44%
Sep 2025 6.9× 1.42%
42 more quarters

Against its own ten years

Low 3.4× High 11.3×
Ten-year median 6.8×
Current reading's percentile 71

EV/Sales against peers

Company EV/Sales
LH Labcorp Holdings Inc. compare 2.2×
DGX Quest Diagnostics Incorporated compare 2.7×
IQV IQVIA Holdings Inc. compare 3.5×
A Agilent Technologies, Inc. compare 6.9×
MTD Mettler-Toledo International, Inc. 7.9×
IDXX IDEXX Laboratories, Inc. compare 9.1×
ILMN Illumina, Inc. compare 9.3×
WAT Waters Corporation compare 10.1×
GH Guardant Health, Inc. compare 20.3×
Diagnostics & Research industry median 5.7×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on MTD